Therefore, gut microbiota dysbiosis occurring in IBD patients can cause BA metabolism alteration, mainly manifested as increased primary BAs and decreased secondary BAs, which aggravates IBD progression by inhibiting FXR and TGR5 activity. This evidence concerns the gene GPBAR1 and inflammatory bowel disease.